XML 49 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Summary Of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 29, 2019
Mar. 30, 2018
Mar. 29, 2019
Mar. 30, 2018
Sep. 28, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Revenues $ 338,258 $ 299,722 $ 640,634 $ 599,249  
Gross margin 301,683 268,695 565,430 537,329  
Provision for income taxes (36,427) (22,432) (12,323) (172,137)  
Net income (loss) attributable to Dolby Laboratories, Inc. $ 73,440 $ 65,216 $ 171,659 $ 11,914  
Diluted (in usd per share) $ 0.70 $ 0.61 $ 1.63 $ 0.11  
Accounts receivable, net $ 178,617   $ 178,617   $ 166,133
Contract assets 244,917   244,917   165,959
Prepaid expenses and other current assets 44,050   44,050   34,890
Deferred taxes 113,409   113,409   74,766
Accrued liabilities 230,708   230,708   243,128
Contract liabilities 20,014   20,014   17,468
Non-current contract liabilities 24,445   24,445   25,887
Retained earnings 2,361,607   2,361,607   2,313,539
Net income $ 73,575 $ 65,350 171,933 $ 12,192  
Deferred income taxes     (38,548) 36,475  
Accounts receivable     (14,221) (39,296)  
Contract assets     (78,949) (44,172)  
Prepaid expenses and other assets     (15,273) (12,647)  
Accounts payable and other liabilities     (14,190) (35,530)  
Contract liabilities     1,061 1,047  
Net cash provided by operating activities     $ 105,844 98,041  
Previously Reported          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Revenues   301,355   589,152  
Gross margin   270,396   527,317  
Provision for income taxes   18,718   185,030  
Net income (loss) attributable to Dolby Laboratories, Inc.   $ 70,631   $ (10,991)  
Diluted (in usd per share)   $ 0.66   $ (0.11)  
Accounts receivable, net         137,151
Contract assets         0
Prepaid expenses and other current assets         35,209
Deferred taxes         101,070
Accrued liabilities         223,594
Contract liabilities         23,931
Non-current contract liabilities         40,064
Retained earnings         2,139,154
Net income       $ (10,713)  
Deferred income taxes       48,332  
Accounts receivable       (69,018)  
Contract assets       0  
Prepaid expenses and other assets       (12,732)  
Accounts payable and other liabilities       (38,124)  
Contract liabilities       324  
Net cash provided by operating activities       98,041  
Restatement Adjustment | Effect of Adopting ASC 606          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Revenues   $ (1,633)   10,097  
Gross margin   (1,701)   10,012  
Provision for income taxes   (3,714)   12,893  
Net income (loss) attributable to Dolby Laboratories, Inc.   $ (5,415)   $ 22,905  
Diluted (in usd per share)   $ (0.05)   $ 0.22  
Accounts receivable, net         28,982
Contract assets         165,959
Prepaid expenses and other current assets         (319)
Deferred taxes         (26,304)
Accrued liabilities         19,534
Contract liabilities         (6,463)
Non-current contract liabilities         (14,177)
Retained earnings         $ 174,385
Net income       $ 22,905  
Deferred income taxes       (11,857)  
Accounts receivable       29,722  
Contract assets       (44,172)  
Prepaid expenses and other assets       85  
Accounts payable and other liabilities       2,594  
Contract liabilities       723  
Net cash provided by operating activities       $ 0